SCHEMBL17201723

SCHEMBL17201723

COc1cc(/C=C/c2ccc(OCc3ccccc3)c(OC)c2)cc(OC(C)=O)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 8/20 0.60
HPGD P15428 3/20 0.57
KDM4E B2RXH2 3/20 0.57
ALDH1A1 P00352 2/20 0.57
HTT P42858 1/20 0.57
HDAC3 O15379 1/20 0.56
HDAC4 P56524 1/20 0.56
HDAC1 Q13547 1/20 0.56
HDAC7 Q8WUI4 1/20 0.56
HDAC2 Q92769 1/20 0.56
HDAC10 Q969S8 1/20 0.56
HDAC11 Q96DB2 1/20 0.56
HDAC8 Q9BY41 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
HDAC9 Q9UKV0 1/20 0.56
HDAC5 Q9UQL6 1/20 0.56
PTGER4 P35408 1/20 0.56
PTGER3 P43115 1/20 0.56
PTGER2 P43116 1/20 0.56
GSK3B P49841 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17201724 1.00 APP (0.60) APPHPGDKDM4EALDH1A1HTT
SCHEMBL17201731 0.96 APP (0.60) APPHPGDKDM4EALDH1A1HTT
SCHEMBL17201732 0.96 APP (0.60) APPHPGDKDM4EALDH1A1HTT
SCHEMBL17201736 0.91 GSK3B (0.56) APPHPGDKDM4EALDH1A1HTT
SCHEMBL17201737 0.91 GSK3B (0.56) APPHPGDKDM4EALDH1A1HTT
SCHEMBL17201746 0.86 APP (0.61) APPHPGDKDM4EALDH1A1HTT
SCHEMBL17201748 0.86 APP (0.61) APPHPGDKDM4EALDH1A1HTT
SCHEMBL38661511 0.85 NQO2 (0.66) APPGSK3BTTRCYP1A1NQO2
SCHEMBL28440296 0.85 APP (0.61) APPHPGDKDM4EALDH1A1HTT
SCHEMBL17201750 0.84 APP (0.53) APPHPGDKDM4EALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11634375-B2 Prenylated hydroxystilbenes Kynan Duke IP, LLC (US) 2023-04-25 US disclosed
US-20220380285-A1 PRENYLATED HYDROXYSTILBENES Kynan Duke IP, LLC (US) 2022-12-01 US disclosed
US-11352310-B2 Prenylated hydroxystilbenes Kynan Duke IP, LLC (US) 2022-06-07 US disclosed
EP-2709975-B1 PRENYLATED HYDROXYSTILBENES KYNAN DUKE IP LLC (US) 2022-01-12 EP disclosed
US-20200331833-A1 PRENYLATED HYDROXYSTILBENES THE UNIVERSITY OF SYDNEY (AU) 2020-10-22 US disclosed
CN-107266297-B Prenylated hydroxystilbenes, pharmaceutical compositions containing the same, use and preparation method thereof 悉尼大学 2020-10-16 CN disclosed
US-10696615-B2 Prenylated hydroxystilbenes THE UNIVERSITY OF SYDNEY (AU) 2020-06-30 US disclosed
US-20190194105-A1 PRENYLATED HYDROXYSTILBENES THE UNIVERSITY OF SYDNEY (AU) 2019-06-27 US disclosed
US-10196335-B2 Prenylated hydroxystilbenes THE UNIVERSITY OF SYDNEY (AU) 2019-02-05 US disclosed
US-20150307429-A1 PRENYLATED HYDROXYSTILBENES Kynan Duke IP, LLC 2015-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10196335-B2 Prenylated hydroxystilbenes HMGB2, CYP51A1, CYP8B1 APP 1081/4885HPGD 110/4885KDM4E 3528/4885
US-20200331833-A1 PRENYLATED HYDROXYSTILBENES HSD11B1, HSD3B1, CYP8B1 APP 1819/4885HPGD 172/4885KDM4E 4261/4885
US-20220380285-A1 PRENYLATED HYDROXYSTILBENES HSD11B1, HSD3B1, CYP8B1 APP 1819/4885HPGD 172/4885KDM4E 4261/4885
US-20150307429-A1 PRENYLATED HYDROXYSTILBENES HMGB2, CYP51A1, CYP8B1 APP 1081/4885HPGD 110/4885KDM4E 3528/4885
US-10696615-B2 Prenylated hydroxystilbenes HSD11B1, CYP8B1, NR1H2 APP 2321/4885HPGD 268/4885KDM4E 3865/4885
US-11352310-B2 Prenylated hydroxystilbenes HSD11B1, HSD3B1, CYP8B1 APP 1819/4885HPGD 172/4885KDM4E 4261/4885
US-20190194105-A1 PRENYLATED HYDROXYSTILBENES HSD11B1, CYP8B1, NR1H2 APP 2321/4885HPGD 268/4885KDM4E 3865/4885
US-11634375-B2 Prenylated hydroxystilbenes HCLS1, IWS1, UTS2R APP 2779/4885HPGD 440/4885KDM4E 3457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.